Beta Bionics, Inc. Common Stock BBNX
$22.18
+15.34%
at last close
Market Cap$997.87 million
P/E Ratio—
Div Yield—
Volume7.72M
52-Week Range
$8.80$32.71
Analyst Ratings
- Consensus
- Moderate Buy — 7 Buy · 4 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $23.60 (+6.4% upside)
Key Stats
- Today's Range
- $18.40 – $22.22
- 50-Day Range
- $12.73 – $22.22
- 52-Week Range
- $8.80 – $32.71
- Volume
- 7.72 million shs
- Average Volume
- 1.27 million shs
- Market Cap
- $997.87 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 3.89
- Price / Sales
- —
Short Interest
- Short Interest
- 0.47%
- Days to Cover
- 1.00
About Beta Bionics, Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Related Stocks
Compare head-to-head: BBNX vs SYK·BBNX vs BSX·BBNX vs RMD·BBNX vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.